Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Nierfunctie en dementierisico
jan 2017 | Dementie
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen